cp-55,940 has been researched along with slv 319 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Behnia, K; Carlson, KE; Ewing, WR; Gu, Z; Hong, Y; Johnghar, S; Keim, WJ; Miller, KJ; Murugesan, N; O'Tanyi, E; Pelleymounter, MA; Rohrbach, KW; Tian, Y; Yang, Y; Zhu, Y | 1 |
1 other study(ies) available for cp-55,940 and slv 319
Article | Year |
---|---|
Characterization of a novel and selective CB1 antagonist as a radioligand for receptor occupancy studies.
Topics: Animals; Anti-Obesity Agents; Brain; Humans; Obesity; Radiography; Radioligand Assay; Rats; Receptor, Cannabinoid, CB1 | 2011 |